Skip to main content

NextCure, Inc. (NXTC)

NASDAQ: NXTC · IEX Real-Time Price · USD
6.02 -0.18 (-2.90%)
Nov 26, 2021 1:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017
Revenue
22.386.3500
Revenue Growth
252.58%---
Gross Profit
22.386.3500
Selling, General & Admin
17.059.613.412.6
Research & Development
46.5534.2219.7912.95
Operating Expenses
63.643.8323.215.55
Operating Income
-41.23-37.48-23.2-15.55
Other Expense / Income
-4.62-3.75-0.4-0.08
Pretax Income
-36.6-33.74-22.8-15.47
Net Income
-36.6-33.74-22.8-15.47
Net Income Common
-36.6-33.74-22.8-15.47
Shares Outstanding (Basic)
281611
Shares Outstanding (Diluted)
281611
Shares Change
75.41%1045.78%0.05%-
EPS (Basic)
-1.33-2.15-16.64-11.30
EPS (Diluted)
-1.33-2.15-16.64-11.30
Free Cash Flow Per Share
-1.89-2.483.60-15.46
Gross Margin
100.00%100.00%--
Operating Margin
-184.22%-590.55%--
Profit Margin
-163.57%-531.54%--
Free Cash Flow Margin
-232.76%-614.37%--
EBITDA
-33.19-31.05-21.12-14.89
EBITDA Margin
-148.32%-489.19%--
EBIT
-36.6-33.74-22.8-15.47
EBIT Margin
-163.57%-531.54%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).